Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Anika Therapeutics (ANIK) Long-Term Debt Repayments (2020)

Historic Long-Term Debt Repayments for Anika Therapeutics (ANIK) over the last 5 years, with Q4 2020 value amounting to $25.0 million.

  • Anika Therapeutics' Long-Term Debt Repayments changed N/A to $25.0 million in Q4 2020 from the same period last year, while for Dec 2021 it was $50.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $50.3 million for FY2020, which is N/A changed from last year.
  • Per Anika Therapeutics' latest filing, its Long-Term Debt Repayments stood at $25.0 million for Q4 2020.
  • In the past 5 years, Anika Therapeutics' Long-Term Debt Repayments ranged from a high of $25.0 million in Q3 2020 and a low of $25.0 million during Q4 2020